The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 12
Depression 3 - Clinical (3)

Sat. May 25, 2024 10:10 AM - 11:35 AM Room 7 (G407)

Chair: Lakshmi Yatham (University of British Columbia)

[SC12-4] Repurposing of gamma-hydroxybutyrate in depression: a randomized placebo-controlled proof-of-concept clinical trial

*Francesco Bavato1, Laura K. Schnider1, Dario A. Dornbierer1, Boris B. Quednow1,3, Hans-Peter Landolt2, Oliver G. Bosch1, Erich Seifritz1 (1. Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Switzerland, 2. Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, 3. Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland)

Keywords:New medication, Drug repurposing, Sleep treatment, Depression, Slow wave sleep

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password